SafeBeat Awarded $2M SBIR Grant to Advance AI-based ECG Analysis for Mobile Therapeutic Monitoring of Atrial Fibrillation Patients: Clinical Study at University of California San Francisco
SafeBeat announced today it has been awarded a Direct to Phase Il Small Business Innovation Research (SBIR grant for approximately $2M from the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH). SafeBeat’s research team is led by Rachita Navara, MD, FACC, FHRS and Kunj Patel, MD, MSc, in collaboration with Edward Gerstenfeld, MD, MS, the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at University of California, San Francisco. The study was designed to validate the SafeBeat Al-based ECG analysis software that enables clinicians to monitor patients starting and continuing medications for atrial fibrillation, all from a mobile phone.
